Home » Stocks » RPHM » Financials » Income Statement

Reneo Pharmaceuticals, Inc. (RPHM)

Stock Price: $13.89 USD -1.11 (-7.40%)
Updated Apr 9, 2021 4:00 PM EDT - Market closed
* No quarterly data available.

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year20202019
Revenue--
Selling, General & Admin3.612.38
Research & Development15.9413.10
Operating Expenses19.5515.47
Operating Income-19.55-15.47
Other Expense / Income-0.09-3.04
Pretax Income-19.47-12.44
Net Income-19.47-12.44
EBITDA-19.45-12.55
EBIT-19.47-12.44